mTOR Expression in Liver Transplant Candidates with Hepatocellular Carcinoma: Impact on Histological Features and Tumour Recurrence

(1) Background: The mammalian target of rapamycin (mTOR) pathway activation is critical for hepatocellular carcinoma (HCC) progression. We aimed to evaluate the mTOR tissue expression in liver transplant (LT) patients and to analyse its influence on post-LT outcomes. (2) Methods: Prospective study i...

Description complète

Enregistré dans:
Détails bibliographiques
Publié dans:Int J Mol Sci
Auteurs principaux: Guerrero, Marta, Ferrín, Gustavo, Rodríguez-Perálvarez, Manuel, González-Rubio, Sandra, Sánchez-Frías, Marina, Amado, Víctor, Pozo, Juan C., Poyato, Antonio, Ciria, Rubén, Ayllón, María D., Barrera, Pilar, Montero, José L., de la Mata, Manuel
Format: Artigo
Langue:Inglês
Publié: MDPI 2019
Sujets:
Article
Accès en ligne:https://ncbi.nlm.nih.gov/pmc/articles/PMC6359509/
https://ncbi.nlm.nih.gov/pubmed/30650598
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3390/ijms20020336
Tags: Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!

Documents similaires